Mal-PEG8-Phe-Lys-PAB-Exatecan structure
|
Common Name | Mal-PEG8-Phe-Lys-PAB-Exatecan | ||
---|---|---|---|---|
CAS Number | 2679821-44-2 | Molecular Weight | 1434.56 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C73H92FN9O20 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Mal-PEG8-Phe-Lys-PAB-ExatecanMal-PEG8-Phe-Lys-PAB-Exatecan (compound 15) is a drug-linker conjugate for ADC, composed of degradable linker Mal-PEG8-Phe-Lys-PAB and toxin molecule Exatecan (HY-13631) composition[1]. |
Name | Mal-PEG8-Phe-Lys-PAB-Exatecan |
---|
Description | Mal-PEG8-Phe-Lys-PAB-Exatecan (compound 15) is a drug-linker conjugate for ADC, composed of degradable linker Mal-PEG8-Phe-Lys-PAB and toxin molecule Exatecan (HY-13631) composition[1]. |
---|---|
Related Catalog | |
References |
[1]. Manel KRAIEM. Treatment of cancer. Patent WO2021151984A1. |
Molecular Formula | C73H92FN9O20 |
---|---|
Molecular Weight | 1434.56 |